Procaterol

Procaterol

Clinical data
Routes of administration	Oral, inhalation
Identifiers
IUPAC name 8-Hydroxy-5-[1-hydroxy-2- (propan-2-ylamino)butyl]-1H-quinolin-2-one
CAS Number	59828-07-8
PubChem CID	4916
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C16H22N2O3
Molar mass	290.357 g/mol

WikiDoc Resources for Procaterol
Articles
Most recent articles on Procaterol Most cited articles on Procaterol Review articles on Procaterol Articles on Procaterol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Procaterol Images of Procaterol Photos of Procaterol Podcasts & MP3s on Procaterol Videos on Procaterol
Evidence Based Medicine
Cochrane Collaboration on Procaterol Bandolier on Procaterol TRIP on Procaterol
Clinical Trials
Ongoing Trials on Procaterol at Clinical Trials.gov Trial results on Procaterol Clinical Trials on Procaterol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Procaterol NICE Guidance on Procaterol NHS PRODIGY Guidance FDA on Procaterol CDC on Procaterol
Books
Books on Procaterol
News
Procaterol in the news Be alerted to news on Procaterol News trends on Procaterol
Commentary
Blogs on Procaterol
Definitions
Definitions of Procaterol
Patient Resources / Community
Patient resources on Procaterol Discussion groups on Procaterol Patient Handouts on Procaterol Directions to Hospitals Treating Procaterol Risk calculators and risk factors for Procaterol
Healthcare Provider Resources
Symptoms of Procaterol Causes & Risk Factors for Procaterol Diagnostic studies for Procaterol Treatment of Procaterol
Continuing Medical Education (CME)
CME Programs on Procaterol
International
Procaterol en Espanol Procaterol en Francais
Business
Procaterol in the Marketplace Patents on Procaterol
Experimental / Informatics
List of terms related to Procaterol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Procaterol, also known as procaterol hydrochloride (USAN), is a short-acting β₂-adrenergic receptor agonist used for the treatment of asthma. It has never been filed for FDA evaluation in the United States, where it is not marketed.

Template:Asthma and copd rx